Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus
- PMID: 17472833
- DOI: 10.1016/s0149-2918(07)80059-2
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus
Comment in
-
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.Clin Ther. 2007 Apr;29(4):759-60; author reply 760-1. Clin Ther. 2007. PMID: 17617300 No abstract available.
Comment on
-
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.Clin Ther. 2006 Aug;28(8):1184-1198. doi: 10.1016/j.clinthera.2006.08.016. Clin Ther. 2006. PMID: 16982296
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical